Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.713 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52317.78 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 45982.75 Kr¶
PnL: ---------------------------------------> -770.25 Kr¶
DD now: ---------------------------------> -1.511 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 10:26:35.495565'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 2.430000 | 2321.000000 | 132.000000 | 6.030000 | 2189.000000 |
| BHG Group | 49 | -2.040000 | 682.570000 | 43.570000 | 6.820000 | 638.999984 |
| Embracer Group B | 26 | 3.820000 | 699.790000 | 37.790000 | 5.710000 | 661.999988 |
| Vitrolife | 3 | 3.640000 | 700.200000 | 23.200000 | 3.430000 | 677.000001 |
| Biotage | 4 | 0.580000 | 622.000000 | 19.000000 | 3.150000 | 603.000000 |
| Indutrade | 5 | 2.140000 | 1338.500000 | 18.500000 | 1.400000 | 1320.000000 |
| Addtech B | 3 | 1.960000 | 717.000000 | 17.000000 | 2.430000 | 699.999999 |
| Eastnine | 6 | -2.610000 | 672.000000 | 15.000000 | 2.280000 | 657.000000 |
| Addnode Group B | 6 | 2.320000 | 766.800000 | 14.800000 | 1.970000 | 751.999998 |
| Sedana Medical | 135 | -1.950000 | 4344.300000 | 13.300000 | 0.310000 | 4330.999935 |
| SynAct Pharma | 9 | -2.400000 | 657.900000 | 12.900000 | 2.000000 | 645.000003 |
| Sdiptech B | 3 | 0.580000 | 834.000000 | 12.000000 | 1.460000 | 822.000000 |
| Xvivo Perfusion | 3 | -0.180000 | 855.000000 | 10.000000 | 1.180000 | 845.000001 |
| Nolato B | 12 | -0.270000 | 656.400000 | 8.400000 | 1.300000 | 648.000000 |
| BONESUPPORT HOLDING | 10 | -0.240000 | 1230.000000 | 6.000000 | 0.490000 | 1224.000000 |
| Latour B | 2 | 1.790000 | 454.000000 | 5.000000 | 1.110000 | 449.000000 |
| NCC B | 7 | -0.210000 | 657.300000 | 3.300000 | 0.500000 | 653.999997 |
| Fortnox | 10 | 3.490000 | 669.600000 | 1.600000 | 0.240000 | 668.000000 |
| Profoto Holding | 7 | 0.000000 | 581.000000 | -1.000000 | -0.170000 | 581.999999 |
| NCC A | 6 | 1.630000 | 597.600000 | -1.400000 | -0.230000 | 598.999998 |
| Lime Technologies | 2 | -1.180000 | 587.000000 | -6.000000 | -1.010000 | 593.000000 |
| Sampo Oyj SDB | 1 | -0.900000 | 497.500000 | -7.500000 | -1.490000 | 505.000000 |
| Volati | 5 | -4.550000 | 566.000000 | -8.000000 | -1.390000 | 574.000000 |
| Investor B | 3 | 0.630000 | 649.650000 | -8.350000 | -1.270000 | 657.999999 |
| SCA A | 4 | 0.000000 | 590.400000 | -8.600000 | -1.440000 | 599.000000 |
| Balco Group | 39 | 0.000000 | 1860.300000 | -14.700000 | -0.780000 | 1874.999997 |
| Humana | 40 | 0.000000 | 643.200000 | -30.800000 | -4.570000 | 674.000000 |
| Lundin Gold | 7 | 1.080000 | 919.800000 | -54.200000 | -5.560000 | 973.999999 |
| Ambea | 68 | 0.940000 | 2482.000000 | -55.000000 | -2.170000 | 2537.000032 |
| Creades A | 7 | 1.030000 | 547.400000 | -63.600000 | -10.410000 | 610.999998 |
| Investor A | 16 | 0.460000 | 3472.000000 | -73.000000 | -2.060000 | 3545.000000 |
| New Wave B | 40 | 0.210000 | 3826.800000 | -89.200000 | -2.280000 | 3916.000000 |
| Gaming Innovation Group | 161 | -0.400000 | 4025.000000 | -163.000000 | -3.890000 | 4187.999942 |
| Wästbygg Gruppen B | 80 | -1.470000 | 2688.000000 | -183.000000 | -6.370000 | 2871.000000 |
| Bactiguard Holding B | 37 | -3.760000 | 2560.400000 | -406.600000 | -13.700000 | 2966.999993 |
| TOTAL | 45972.410000 | -780.590000 | -1.52909% | 46752.999863 |
Updated:¶
'2023-06-13 10:25:48.962396'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
